Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cellsDavid Lamb(Boehringer Ingelheim (Germany)), Wolfgang Sommergruber(Hochschule Campus Wien)OncotargetApril 7, 202010.18632/oncotarget.27545Cited by 9SaveCiteExport RISWatch citationsRelated PapersRORγt inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthma|Respiratory Research|2021|24